These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12395930)

  • 1. Site-specific 32P-labeling of cytokines, monoclonal antibodies, and other protein substrates for quantitative assays and therapeutic application.
    Clark WA; Izotova L; Philipova D; Wu W; Lin L; Pestka S
    Biotechniques; 2002 Oct; Suppl():76-8, 80-7. PubMed ID: 12395930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of protein kinase recognition sites into proteins: a review of their preparation, advantages, and applications.
    Pestka S; Lin L; Wu W; Izotova L
    Protein Expr Purif; 1999 Nov; 17(2):203-14. PubMed ID: 10545268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial expression of a kemptide fusion protein facilitates 32P labeling of a humanized, anti-carcinoembryonic antigen (hMN-14) antibody fragment.
    Leung SO; Karacay H; Losman MJ; Griffiths GL; Goldenberg DM; Hansen HJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5968s-5972s. PubMed ID: 7493378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of phosphorylatable chimeric monoclonal antibody CC49 with a casein kinase I recognition site.
    Lin L; Gillies SD; Schlom J; Pestka S
    Protein Expr Purif; 1999 Feb; 15(1):83-91. PubMed ID: 10024474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of phosphorylatable monoclonal antibody CC49 with a casein kinase II recognition site.
    Lin L; Gillies SD; Schlom J; Pestka S
    Anticancer Res; 1998; 18(6A):3971-8. PubMed ID: 9891433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [gamma-32P]-ATP.
    Neri D; Petrul H; Winter G; Light Y; Marais R; Britton KE; Creighton AM
    Nat Biotechnol; 1996 Apr; 14(4):485-90. PubMed ID: 9630925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment.
    Magdelaine-Beuzelin C; Kaas Q; Wehbi V; Ohresser M; Jefferis R; Lefranc MP; Watier H
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):210-25. PubMed ID: 17624800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs.
    Krüger M; Kötter S; Grützner A; Lang P; Andresen C; Redfield MM; Butt E; dos Remedios CG; Linke WA
    Circ Res; 2009 Jan; 104(1):87-94. PubMed ID: 19023132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugation of monoclonal antibodies to a synthetic peptide substrate for protein kinase: a method for labelling antibodies with 32P.
    Foxwell BM; Band HA; Long J; Jeffery WA; Snook D; Thorpe PE; Watson G; Parker PJ; Epenetos AA; Creighton AM
    Br J Cancer; 1988 May; 57(5):489-93. PubMed ID: 3395553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of two novel tag-based labelling technologies for site-specific modification of proteins.
    Tirat A; Freuler F; Stettler T; Mayr LM; Leder L
    Int J Biol Macromol; 2006 Aug; 39(1-3):66-76. PubMed ID: 16503347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for the 32P labeling of peptides or peptide nucleic acid oligomers.
    Kozlov IA; Nielsen PE; Orgel LE
    Bioconjug Chem; 1998; 9(4):415-7. PubMed ID: 9667944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Terminal peptide labeling strategy for incorporation of isotopic tags: a method for the determination of site-specific absolute phosphorylation stoichiometry.
    Zhang X; Jin QK; Carr SA; Annan RS
    Rapid Commun Mass Spectrom; 2002; 16(24):2325-32. PubMed ID: 12478578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A calmodulin-regulated protein kinase linked to neuron survival is a substrate for the calmodulin-regulated death-associated protein kinase.
    Schumacher AM; Schavocky JP; Velentza AV; Mirzoeva S; Watterson DM
    Biochemistry; 2004 Jun; 43(25):8116-24. PubMed ID: 15209507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic construction of a phosphorylation site in ricin A chain: specific radiolabeling of recombinant proteins for localization and degradation studies.
    Fryxell D; Li BY; Mohanraj D; Johnson B; Ramakrishnan S
    Biochem Biophys Res Commun; 1995 May; 210(2):253-9. PubMed ID: 7755598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic MS-based approach for identifying in vitro substrates of PKA and PKG in rat uteri.
    Huang SY; Tsai ML; Chen GY; Wu CJ; Chen SH
    J Proteome Res; 2007 Jul; 6(7):2674-84. PubMed ID: 17564427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.